Showing 101 - 120 results of 326 for search '"diabetic retinopathy"', query time: 0.05s Refine Results
  1. 101
  2. 102

    Difference in the Vitreal Protein Profiles of Patients with Proliferative Diabetic Retinopathy with and without Intravitreal Conbercept Injection by Chen Zou, Minjie Zhao, Jingjing Yu, Dandan Zhu, Yunzhi Wang, Xinping She, Yanan Hu, Zhi Zheng

    Published 2018-01-01
    “…To examine the difference in the vitreal protein profiles of patients with proliferative diabetic retinopathy (PDR) with and without preoperative intravitreal conbercept (IVC) treatment. …”
    Get full text
    Article
  3. 103
  4. 104
  5. 105
  6. 106

    Systemic Factors Related to Intraocular Levels of Interleukin-6 and Vascular Endothelial Growth Factor in Diabetic Retinopathy by Byung Ju Jung, Mee Yon Lee, Sohee Jeon

    Published 2019-01-01
    “…An appreciation for the relationship between systemic factors and intraocular cytokines may help elucidate the complex pathophysiology of diabetic retinopathy.…”
    Get full text
    Article
  7. 107

    Efficacy and Safety of Intravitreal Conbercept, Ranibizumab, and Triamcinolone on 23-Gauge Vitrectomy for Patients with Proliferative Diabetic Retinopathy by Jinglin Cui, Hong Chen, Hang Lu, Fangtian Dong, Dongmei Wei, Yan Jiao, Steve Charles, Weikuan Gu, Lin Wang

    Published 2018-01-01
    “…To compare the effect and safety of intravitreal conbercept (IVC), intravitreal ranibizumab (IVR), or intravitreal triamcinolone acetonide (IVTA) injection on 23-gauge (23-G) pars plana vitrectomy (PPV) for proliferative diabetic retinopathy (PDR). Methods. Fifty patients (60 eyes) of varying degrees of PDR were randomly grouped into 3 groups (1 : 1 : 1) (n=20 in each group). …”
    Get full text
    Article
  8. 108

    Activated Growth Factor From Platelets as Treatment for Diabetic Retinopathy Through Antioxidant-Oxidative Stress Pathway by Amin R, Hidayat R, Maritska Z, Putri TW

    Published 2025-01-01
    “…Mohammad Hoesin General Hospital, Jl Dr Moh Ali KM 3.5, Palembang, South Sumatera, 30114, Indonesia, Tel +62 882 2505 3819, Email ramziamin20@gmail.comBackground: Reactive oxygen species (ROS) is known to play a significant role in the activation of chronic inflammatory processes in diabetic retinopathy. This study was aimed to evaluate activated growth factor (AGF) from platelet for diabetic retinopathy treatment, utilizing an in vivo investigation to regulate the antioxidant-oxidative stress pathway.Methods: The activated growth factor was initially derived by extracting intravenous blood from the rats. …”
    Get full text
    Article
  9. 109

    Automated multidimensional deep learning platform for referable diabetic retinopathy detection: a multicentre, retrospective study by Chi Pui Pang, Weiqi Chen, Mingzhi Zhang, Tsz Kin Ng, Yi Zheng, Guihua Zhang, Jian-Wei Lin, Ji Wang, Jie Ji, Ling-Ping Cen, Peiwen Xie, Yongqun Xiong, Hanfu Wu, Dongjie Li

    Published 2022-07-01
    “…Objective To develop and validate a real-world screening, guideline-based deep learning (DL) system for referable diabetic retinopathy (DR) detection.Design This is a multicentre platform development study based on retrospective, cross-sectional data sets. …”
    Get full text
    Article
  10. 110
  11. 111

    Blockade of Vascular Endothelial Growth Factor Receptor 1 Prevents Inflammation and Vascular Leakage in Diabetic Retinopathy by Jianbo He, Hong Wang, Ying Liu, Wen Li, Dorothy Kim, Hu Huang

    Published 2015-01-01
    “…Diabetic retinopathy (DR) is a leading cause of blindness in working age adults. …”
    Get full text
    Article
  12. 112

    NADPH Oxidase versus Mitochondria-Derived ROS in Glucose-Induced Apoptosis of Pericytes in Early Diabetic Retinopathy by Nik M. Mustapha, Joanna M. Tarr, Eva M. Kohner, Rakesh Chibber

    Published 2010-01-01
    “…NADPH oxidase and not mitochondria-derived ROS is responsible for the accelerated apoptosis of pericytes in diabetic retinopathy.…”
    Get full text
    Article
  13. 113
  14. 114
  15. 115

    Potent Oral Hypoglycemic Agents for Microvascular Complication: Sodium-Glucose Cotransporter 2 Inhibitors for Diabetic Retinopathy by Eun Hyung Cho, Se-Jun Park, Seongwook Han, Ji Hun Song, Kihwang Lee, Yoo-Ri Chung

    Published 2018-01-01
    “…The purpose of this study was to investigate the effects of sodium-glucose cotransporter 2 inhibitors (SGLT2i) on the progression of diabetic retinopathy (DR) in patients with type 2 diabetes. …”
    Get full text
    Article
  16. 116
  17. 117
  18. 118
  19. 119

    Quantification of Microvascular Density of the Optic Nerve Head in Diabetic Retinopathy Using Optical Coherence Tomographic Angiography by Jianfeng Huang, Bodi Zheng, Yingyi Lu, Xiaoya Gu, Hong Dai, Tong Chen

    Published 2020-01-01
    “…To quantify the capillary density of the optic nerve head in healthy control eyes and different stages of diabetic retinopathy (DR) eyes and identify the parameters to detect eyes with or without DR using optical coherence tomographic angiography (OCTA). …”
    Get full text
    Article
  20. 120